Health ❯ Healthcare ❯ Regulatory Affairs

Drug Approval

European Medicines Agency Anvisa FDA MHRA Clinical Guidelines ANVISA Clinical Trials NICE Guidelines European Commission FDA Approval

UK Regulator Approves Eli Lilly’s Foundayo Tablet for Weight Loss and Type 2 Diabetes

The MHRA’s authorisation allows private prescriptions now, with NHS funding subject to a NICE cost‑effectiveness review.

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

Anvisa Registers Five New Semaglutide Pens

Novartis Returns to Sales Growth as New Drugs Offset Entresto Slump

Donanemab Slows Alzheimer's Decline, New AAIC Data Show

EMA Committee Recommends Revoking Tavneos Authorization

MHRA Approves Wegovy Daily Pill for Weight Loss in UK

EU Clears Sanofi’s Sarclisa for Subcutaneous Use With Portable Injector

NEJM Paper Shows Zanidatamab Triplet Extends Survival Over Trastuzumab in First‑Line HER2+ Gastroesophageal Cancer

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

BioMarin Says Voxzogo Raised Growth Rates in Children With Hypochondroplasia

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

Novo Nordisk’s Oral Semaglutide Lowers HbA1c in Teens in Pivotal Trial

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

HHS Chief Distances From FDA Replimune Denial as Oncologists Dispute Review

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

Health Canada Approves Neffy, First Nasal Epinephrine for Anaphylaxis

UK Regulators Approve Single-Dose 7.2mg Wegovy Pen for Weekly Use

Multiple Indian Drugmakers Win U.S. Clearance to Sell Farxiga Generic